Skip to main content
Clinical Trials/NCT05660434
NCT05660434
Completed
Not Applicable

Using Aromatherapy for Comfort, Ease, and Stress for Adults Being Treated for Substance Use Disorder in North Central Appalachia: A Randomized Controlled Trial

West Virginia University1 site in 1 country100 target enrollmentSeptember 5, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Use Disorders
Sponsor
West Virginia University
Enrollment
100
Locations
1
Primary Endpoint
Examine Feasibility (Eligible Participant Recruitment)
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this clinical trial study is to see if Bergamot, an aroma therapy essential oil, has any effect on comfort, ease, and stress. Participants will be asked to use a bergamot aroma inhaler, which is a small tube about the size of a lipstick container, at least three times a day for one week. Comfort, ease, and stress will be measured with self-report survey at the beginning and at the end of the week. In addition, participants will be asked to complete a daily logbook to record use of the inhaler. The study lasts for one week (7 days). The aims of this study are to explore the effects of Bergamot essential oil on comfort, ease, and stress in adults in a substance use disorder (SUD) treatment program, and to evaluate the feasibility of this type of aroma therapy intervention.

Detailed Description

Statement of purpose: The purpose of the study is to examine the effect of an aromatic intervention using bergamot essential oil on comfort, ease, and stress in adults in a SUD recovery program Research Question: What are differences in comfort, ease, and stress for persons in a substance use disorder program who receive aromatic intervention and for those who do not? Conceptual framework: An integrated theoretical framework combining the theory of comfort (Kolcaba, 2003) and the concept of welcoming ease (Reven, 2022) will be used as theoretical guidance for this study. Aims and Objectives: Specific Aim #1: Evaluate the feasibility and acceptability of an aromatherapy intervention by examining recruitment, enrollment and retention rates, intervention fidelity, and cost analysis. Specific Aim #2: Pilot test bergamot essential oil intervention with adults in a substance use disorder recovery program. Background: Appalachia is at the epicenter of the opioid addiction crisis with hardly a family left untouched by the devastating consequences. Those who make it to recovery programs are often plagued by anxiety and depression. Those in treatment have identified increasing the level of comfort during substance use recovery as vital. Integrating aromatherapy could help improve perception of comfort and reduce stress thus enhancing recovery program progression. Methods: The study uses a parallel-randomized control group comparison design. Data will be collected from participants daily and post intervention. For Aim #1, descriptive and bivariate analysis will be conducted. Statistical assumptions will be tested. Sample demographics will be reported. For Aim #2, descriptive statistics will be used as well as participant recruitment, enrollment, and retention rates. Reasons for non-participation and attrition will be recorded. Percentage of intervention consistency will be calculated and cost of the intervention will be determined. Timeline: The proposed study would begin as soon as grant funding is available with projected timeline being August 2022 to December 2023.

Registry
clinicaltrials.gov
Start Date
September 5, 2022
End Date
March 15, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Marian Reven

Assistant Professor, Principle Investigator

West Virginia University

Eligibility Criteria

Inclusion Criteria

  • Participants can be at any level of treatment, including peer recovery coach program at West Virginia University Comprehensive Opioid Addiction Treatment (COAT) program
  • All participants must be alert and oriented
  • Provide written consent
  • Able to read and write English

Exclusion Criteria

  • Have a medical history of asthma or other serious respiratory disease
  • Known allergy to citrus.
  • Dislike of Bergamot

Outcomes

Primary Outcomes

Examine Feasibility (Eligible Participant Recruitment)

Time Frame: Up to 18 months

Determine feasibility by assessing the number of eligible participants recruited.

Examine Feasibility (Eligible Participant Enrollment)

Time Frame: Up to 18 months

Determine feasibility by assessing how many eligible participants enroll.

Examine Feasibility (Participant Retention)

Time Frame: Up to 18 months

Determine feasibility by assessing count of participants retained.

Examine Fidelity of the Intervention

Time Frame: Up to 7 days

Determine fidelity by assessing the count of participants that completed the intervention as directed as shown in the daily logbook.

Secondary Outcomes

  • Change in Perceived Comfort Level(Pre test prior to day 1 to Post test after 1 week)
  • Change in Perceived Ease Level(Pre test prior to day 1 to Post test after 1 week)
  • Change in the Depression, Anxiety, and Stress Scale (DASS-21)(Pre test prior to day 1 to Post test after 1 week)
  • Visual Analogue Scale to Assess Daily Perceived Comfort(7 days)

Study Sites (1)

Loading locations...

Similar Trials